Corrections

• Correction in the article by de Juan Bagudá et al. “Repetitive ambulatory levosimendan as a bridge to heart transplantation”, Rev Esp Cardiol. 2024;77:290-301

  Rev Esp Cardiol. 2024;77:802

• Correction in article by Juzga-Corrales et al. «Characteristics and outcomes of the Spanish registry for pediatric patients with bicuspid aortic valve (REVAB)», Rev Esp Cardiol. 2023;76:961-969

  Rev Esp Cardiol. 2024;77:358-9

• Correction in article by Buendía Fuentes et al. “CA125: a new biomarker in patients with Fontan circulation”, Rev Esp Cardiol. 2023;76:112-120

  Rev Esp Cardiol. 2023;76:670

• Correction in article by Evangelista Masip et al. «Spanish Registry of Acute Aortic Syndrome (RESA). Changes in therapeutic management and lower mortality in acute aortic syndrome». Rev Esp Cardiol. 2022;75:817-825

  Rev Esp Cardiol. 2023;76:392-5

• Correction in article by Baka et al. “Consideration of nondipping heart rate during ambulatory blood pressure monitoring to improve cardiovascular risk assessment”, Rev Esp Cardiol. 2022;75:355-356

  Tomas Baka, Alberto Domínguez-Rodríguez, Fedor Simko

  Rev Esp Cardiol. 2022;75:974

• Correction in the article «Aorta Code: a pilot study of a health care network for patients with acute aortic syndrome», Rev Esp Cardiol. 2022;75:88-102

  Rev Esp Cardiol. 2022;75:697-9

• Correction in editorial comments by the SEC Guidelines Committee on ESC 2020 CPG on sports, Rev Esp Cardiol. 2021;74:488-493; NSTEACS, Rev Esp Cardiol. 2021;74:482-487; congenital heart disease, Rev Esp Cardiol. 2021;74:371-377; and atrial fibrillation, Rev Esp Cardiol. 2021;74:378-383; and ESC 2016 CPG on atrial fibrillation, Rev Esp Cardiol. 2017;70:2-8

  Rev Esp Cardiol. 2022;75:357

• Correction in the article «Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas», Rev Esp Cardiol. 2021;74:790-799

  Rev Esp Cardiol. 2022;75:192

• Correction in article by Cosín-Sales et al. «Telemedicine for patients with valvular heart disease or aortic disease in the era of COVID-19. Response». Rev Esp Cardiol. 2021;74:362-363

  Rev Esp Cardiol. 2021;74:729

• Correction in article by Rodríguez et al. “Exercising in times of COVID-19: what do experts recommend doing within four walls?”, Rev Esp Cardiol. 2020;73:527-529

  Rev Esp Cardiol. 2021;74:366

• Correction in the article by the SEC Working Group and Expert Reviewers for the 2019 ESC/EAS guidelines for the management of dyslipidaemias, and SEC Guidelines Committe “Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias”, Rev Esp Cardiol. 2020;73:348–353

  Rev Esp Cardiol. 2021;74:283

• Correction in article by Bonanad et al. “Coronavirus: the geriatric emergency of 2020. Joint document of the Section on Geriatric Cardiology of the Spanish Society of Cardiology and the Spanish Society of Geriatrics and Gerontology”, Rev Esp Cardiol. 2020;73:569-576

  Rev Esp Cardiol. 2021;74:205-6

• Correction in article by Cano Pérez et al. “Spanish Pacemaker Registry. 16th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2018)”, Rev Esp Cardiol. 2019;72:944–953

  Rev Esp Cardiol. 2021;74:205

• Correction in article by Jordán-Martínez et al. “Atrioventricular block in patients undergoing treatment with bradycardic drugs. Predictors of pacemaker requirement”, Rev Esp Cardiol. 2020:73:554-560

  Rev Esp Cardiol. 2020;73:971

• Correction in article by Fernández González et al. “Late esophageal perforation due to an Amplatzer device in scimitar syndrome”, Rev Esp Cardiol. 2020;73:324

  Rev Esp Cardiol. 2020;73:787

• Correction in article by Malo et al. “Persistence With Statins in Primary Prevention of Cardiovascular Disease: Findings From a Cohort of Spanish Workers”, Rev Esp Cardiol. 2018;71:26-32

  Rev Esp Cardiol. 2020;73:434

• Correction in article by Anguita Sánchez et al. “Cardiologists and the Cardiology of the Future. Vision and proposals of the Spanish Society of Cardiology for the Cardiology of the 21st Century”, Rev Esp Cardiol. 2019;72:649-657

  Rev Esp Cardiol. 2020;73:434-5

• Correction in article by Galian-Gay et al. “Determinants of long-term outcome of repaired pulmonary valve stenosis”, Rev Esp Cardiol. 2020;73:131-138

  Rev Esp Cardiol. 2020;73:435

• Correction to article by Crespo et al. “Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry”, Rev Esp Cardiol. 2020;73:313–323.

  Rev Esp Cardiol. 2020;73:342

• Correction in article by Santas et al. “International Normalized Ratio and Mortality Risk in Acute Heart Failure and Nonvalvular Atrial Fibrillation Patients Receiving Vitamin K Antagonists”, Rev Esp Cardiol. 2019;72:616-624

  Rev Esp Cardiol. 2020;73:190